Skip to content

Sean Parker

Sean Parker

Board Member

Sean Parker is a philanthropist and entrepreneur with a record of launching genre-defining companies and organizations. He is the founder and President of the Parker Foundation, which focuses on four areas: Life Sciences, Global Public Health, Civic Engagement, and the Arts.

Mr. Parker formed the Parker Institute for Cancer Immunotherapy (PICI) in 2016 to research the relationship between the immune system and cancer. In the ensuing years, PICI has evolved into a leader in the immunotherapy field for cutting edge research collaboration and clinical development, including funding a landmark human trial using CRISPR technology. 

In addition to cancer research, Mr. Parker has led many initiatives that revolutionized the civic and social landscape. He was the co-founder of Napster at age 19 and of Plaxo at 21. In 2004 he partnered with Mark Zuckerberg to found Facebook and served as its first president. In 2007 he co-founded Causes on Facebook, which registered 180 million people to donate money and take action around social issues. During his tenure as Managing Partner at Founders Fund, Mr. Parker became Spotify’s first American investor. Mr. Parker is also chairman and founder of the Economic Innovation Group (EIG), based in Washington D.C. He was a key architect behind EIG’s groundbreaking Opportunity Zones program, a community investment tool that connects private capital with low-income communities across America.

In addition to serving as chairman of the board at the Economic Innovation Group and the Parker Institute for Cancer Immunotherapy, Mr. Parker is on the Museum of Contemporary Art’s Board of Trustees.

He lives in Los Angeles with his wife Alexandra and their two children.

Your support turns hope into action

Donate to the Barack Obama Foundation to inspire, empower, and connect the next generation to change their world.

Donate to the Barack Obama Foundation. The Barack Obama Foundation is registered as a 501(c)(3) non-profit organization (EIN 46-4950751).